United States Biotechnology & Medical Research

Navidea Biopharmaceuticals Inc (NAVB)

Track

Track

Ticker: NAVB Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Navidea Biopharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.4
Scott John K Jr. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
75.70
Quantity 41,442
Value US$1,833,202
2.0
Witter Malcolm G Non-Executive Director
Transaction date
Purchase
Price
19.28
Quantity 32,413 -23.9%
Value US$4,659,291
2.0
Witter Malcolm G Non-Executive Director
Transaction date
Purchase
Price
422.73
Quantity 12,905 -24.9%
Value US$1,923,881
2.0
Witter Malcolm G Non-Executive Director
Transaction date
Purchase
Price
2.07
Quantity 21,500 +84.3%
Value US$44,505
2.0
Witter Malcolm G Non-Executive Director
Transaction date
Purchase
Price
2.31
Quantity 15,000 +142.9%
Value US$34,650
2.0
Witter Malcolm G Non-Executive Director
Transaction date
Purchase
Price
2.07
Quantity 5,000 +90.9%
Value US$10,350
1.4
Scott John K Jr. Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 5,000 +0.1%
Value US$25,000
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.08
Quantity 5,000 +38.6%
Value US$5,400
1.4
Scott John K Jr. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 2,373,529 +41.9%
Value US$2,017,500
Scott John K Jr. Large shareholder
Transaction date
Purchase
Price
0.90
Quantity 555,555 +10.9%
Value US$500,000
1.4
Scott John K Jr. Large shareholder
Transaction date
Purchase
Price
0.75
Quantity 4,000,000 +359.4%
Value US$3,000,000
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.26
Quantity 1,000 +8.4%
Value US$1,258
3.2
Rouan Sarah Kathryn
Transaction date
Purchase
Price
1.46
Quantity 3,350 +67.0%
Value US$4,904
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.46
Quantity 1,000 +9.1%
Value US$1,463
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.45
Quantity 1,500 +15.9%
Value US$2,180
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.45
Quantity 1,000 +11.8%
Value US$1,448
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.84
Quantity 2,000 +31.0%
Value US$3,679
1.4
Bruck Claudine
Transaction date
Purchase
Price
1.90
Quantity 2,550 +51.0%
Value US$4,855
2.0
Latkin Jed CEO, COO & CFO Executive Director
Transaction date
Purchase
Price
1.91
Quantity 2,400 +59.3%
Value US$4,595
1.4
Scott John K Jr. Large shareholder
Transaction date
Purchase
Price
0.14
Quantity 357,143 +1.6%
Value US$50,000
Regan William J. SVP & CCO Officer
Transaction date
Purchase
Price
0.53
Quantity 20,000 +13.1%
Value US$10,586
Latkin Jed COO and CFO
Transaction date
Purchase
Price
0.44
Quantity 7,600 +17.9%
Value US$3,317
Latkin Jed COO and CFO
Transaction date
Purchase
Price
0.45
Quantity 11,200 +35.7%
Value US$5,039
Latkin Jed COO and CFO
Transaction date
Purchase
Price
0.45
Quantity 14,159 +82.3%
Value US$6,387
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
1.31
Quantity 10,000 +4.7%
Value US$13,098
GOLDBERG MICHAEL M Non-Executive Director
Transaction date
Purchase
Price
1.12
Quantity 28,359 +10.9%
Value US$31,890
GOLDBERG MICHAEL M Non-Executive Director
Transaction date
Purchase
Price
1.06
Quantity 71,641 +37.8%
Value US$75,853
FORD BRENDAN A Non-Executive Director
Transaction date
Purchase
Price
1.03
Quantity 10,000 +5.9%
Value US$10,300
Nordlicht Mark Large shareholder
Transaction date
Sale
Price
1.36
Quantity 60,000 -0.4%
Value US$81,552
Regan William J. SVP-Global Reg Affairs&Quality Officer
Transaction date
Purchase
Price
1.43
Quantity 100 +1.0%
Value US$143
Regan William J. SVP-Global Reg Affairs&Quality Officer
Transaction date
Purchase
Price
1.43
Quantity 500 +5.3%
Value US$712
Regan William J. SVP-Global Reg Affairs&Quality Officer
Transaction date
Purchase
Price
1.43
Quantity 4,400 +88.0%
Value US$6,283
PYKETT MARK JEROME CEO Executive Director
Transaction date
Purchase
Price
1.34
Quantity 10,000 +3.5%
Value US$13,400
PYKETT MARK JEROME CEO Executive Director
Transaction date
Purchase
Price
1.35
Quantity 10,900 +2.8%
Value US$14,715
Cope Frederick O SVP Officer
Transaction date
Purchase
Price
1.43
Quantity 3,500 +4.0%
Value US$5,005
LARSON BRENT L EVP, CFO, Treas & Secy Officer
Transaction date
Purchase
Price
1.39
Quantity 5,000 +1.8%
Value US$6,950
FORD BRENDAN A Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 20,000 +16.8%
Value US$29,000
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
1.36
Quantity 20,000 +15.8%
Value US$27,158
Tulip Thomas H. EVP & Chief Business Officer Officer
Transaction date
Purchase
Price
2.82
Quantity 17,500 +63.6%
Value US$49,350
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.70
Quantity 1,850 +0.5%
Value US$4,995
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
2.70
Quantity 7,000 +5.9%
Value US$18,893
Regan William J. SVP-Global Regulatory Strategy Officer
Transaction date
Purchase
Price
2.71
Quantity 5,000 +inf%
Value US$13,550
FORD BRENDAN A Non-Executive Director
Transaction date
Purchase
Price
2.71
Quantity 5,000 +4.4%
Value US$13,550
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Purchase
Price
2.56
Quantity 37,030 +0.5%
Value US$94,797
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.24
Quantity 4,911 -0.1%
Value US$15,912
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.22
Quantity 21,700 -0.3%
Value US$69,874
Tulip Thomas H. EVP & Chief Business officer
Transaction date
Purchase
Price
2.70
Quantity 15,000 +120.0%
Value US$40,500
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
2.64
Quantity 5,000 +6.9%
Value US$13,185
FORD BRENDAN A Non-Executive Director
Transaction date
Purchase
Price
2.64
Quantity 5,000 +7.5%
Value US$13,200
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.64
Quantity 4,000 +1.3%
Value US$10,552
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.69
Quantity 269,919 -3.8%
Value US$996,001
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.75
Quantity 20,500 -0.3%
Value US$76,875
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.61
Quantity 118,731 -1.6%
Value US$428,619
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.71
Quantity 2,200 -0.0%
Value US$8,162
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.78
Quantity 64,900 -0.9%
Value US$245,322
Platinum-Montaur Life Sciences, LLC Large shareholder
Transaction date
Sale
Price
3.80
Quantity 205,521 -2.8%
Value US$780,980
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
3.58
Quantity 5,000 +7.5%
Value US$17,895
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
2.54
Quantity 7,814 -0.3%
Value US$19,848
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
2.45
Quantity 42,186 -1.5%
Value US$103,356
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
2.19
Quantity 10,000 -0.4%
Value US$21,900
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
2.25
Quantity 6,100 -0.2%
Value US$13,725
BROWN RODGER A Vice President Officer
Transaction date
Planned sale
Price
2.76
Quantity 28,715 -13.1%
Value US$79,253
LARSON BRENT L SVP, CFO, Treas & Secy Officer
Transaction date
Planned sale
Price
2.75
Quantity 12,500 -4.5%
Value US$34,375
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
2.89
Quantity 50,000 -1.9%
Value US$144,500
DRAKE PETER F Non-Executive Director
Transaction date
Purchase
Price
3.08
Quantity 10,000 +inf%
Value US$30,780
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.56
Quantity 1,100 +inf%
Value US$2,816
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.56
Quantity 100 +3.1%
Value US$256
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.60
Quantity 500 +18.5%
Value US$1,300
PYKETT MARK JEROME Pres. & CEO Executive Director
Transaction date
Purchase
Price
2.61
Quantity 2,700 +inf%
Value US$7,047
Troup Gordon A Non-Executive Director
Transaction date
Purchase
Price
2.61
Quantity 10,000 +25.0%
Value US$26,100
FORD BRENDAN A Non-Executive Director
Transaction date
Purchase
Price
2.51
Quantity 20,000 +66.7%
Value US$50,200
Rowinsky Eric K Non-Executive Director
Transaction date
Purchase
Price
2.55
Quantity 15,000 +inf%
Value US$38,250
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
4.52
Quantity 234,000 -8.2%
Value US$1,057,680
BUPP DAVID C Non-Executive Director
Transaction date
Planned sale
Price
4.74
Quantity 233,000 -8.4%
Value US$1,104,420
Blair Anthony K VP-Manufacturing & Operations Officer
Transaction date
Sale
Price
5.22
Quantity 50,000 -100.0%
Value US$261,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-03 2022-04-10 B Purchase
1.4
Scott John K Jr.
Non-Executive Director Large shareholder
41,442
75.70
US$1,833,202 		41,442 75.70 US$1,833,202
2021-09-17 2021-09-17 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
32,413 -23.9%
19.28
US$4,659,291 		32,413 -23.9% 19.28 US$4,659,291
2021-04-26 2021-04-23 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
12,905 -24.9%
422.73
US$1,923,881 		12,905 -24.9% 422.73 US$1,923,881
2021-03-29 2021-03-29 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
21,500 +84.3%
2.07
US$44,505 		21,500 +84.3% 2.07 US$44,505
2021-03-03 2021-03-03 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
15,000 +142.9%
2.31
US$34,650 		15,000 +142.9% 2.31 US$34,650
2020-12-30 2020-12-28 B Purchase
2.0
Witter Malcolm G
Non-Executive Director
5,000 +90.9%
2.07
US$10,350 		5,000 +90.9% 2.07 US$10,350
2020-09-02 2020-08-30 B Purchase
1.4
Scott John K Jr.
Large shareholder
5,000 +0.1%
5.00
US$25,000 		5,000 +0.1% 5.00 US$25,000
2020-02-20 2020-02-20 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
5,000 +38.6%
1.08
US$5,400 		5,000 +38.6% 1.08 US$5,400
2020-02-19 2020-02-13 B Purchase
1.4
Scott John K Jr.
Large shareholder
2,373,529 +41.9%
0.85
US$2,017,500 		2,373,529 +41.9% 0.85 US$2,017,500
2019-12-11 2019-12-06 B Purchase Scott John K Jr. Large shareholder
555,555 +10.9%
0.90
US$500,000 		555,555 +10.9% 0.90 US$500,000
2019-06-21 2019-06-18 B Purchase
1.4
Scott John K Jr.
Large shareholder
4,000,000 +359.4%
0.75
US$3,000,000 		4,000,000 +359.4% 0.75 US$3,000,000
2019-06-07 2019-06-05 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +8.4%
1.26
US$1,258 		1,000 +8.4% 1.26 US$1,258
2019-05-21 2019-05-17 B Purchase
3.2
Rouan Sarah Kathryn
3,350 +67.0%
1.46
US$4,904 		3,350 +67.0% 1.46 US$4,904
2019-05-17 2019-05-17 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +9.1%
1.46
US$1,463 		1,000 +9.1% 1.46 US$1,463
2019-05-17 2019-05-16 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,500 +15.9%
1.45
US$2,180 		1,500 +15.9% 1.45 US$2,180
2019-05-15 2019-05-15 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
1,000 +11.8%
1.45
US$1,448 		1,000 +11.8% 1.45 US$1,448
2019-05-15 2019-05-14 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
2,000 +31.0%
1.84
US$3,679 		2,000 +31.0% 1.84 US$3,679
2019-05-15 2019-05-13 B Purchase
1.4
Bruck Claudine
2,550 +51.0%
1.90
US$4,855 		2,550 +51.0% 1.90 US$4,855
2019-05-15 2019-05-13 B Purchase
2.0
Latkin Jed

CEO, COO & CFO

Executive Director
2,400 +59.3%
1.91
US$4,595 		2,400 +59.3% 1.91 US$4,595
2019-03-25 2019-03-22 B Purchase
1.4
Scott John K Jr.
Large shareholder
357,143 +1.6%
0.14
US$50,000 		357,143 +1.6% 0.14 US$50,000
2017-07-03 2017-06-29 B Purchase Regan William J.

SVP & CCO

Officer
20,000 +13.1%
0.53
US$10,586 		20,000 +13.1% 0.53 US$10,586
2017-05-31 2017-05-30 B Purchase Latkin Jed

COO and CFO
7,600 +17.9%
0.44
US$3,317 		7,600 +17.9% 0.44 US$3,317
2017-05-23 2017-05-22 B Purchase Latkin Jed

COO and CFO
11,200 +35.7%
0.45
US$5,039 		11,200 +35.7% 0.45 US$5,039
2017-05-23 2017-05-19 B Purchase Latkin Jed

COO and CFO
14,159 +82.3%
0.45
US$6,387 		14,159 +82.3% 0.45 US$6,387
2015-06-01 2015-05-29 B Purchase Troup Gordon A Non-Executive Director
10,000 +4.7%
1.31
US$13,098 		10,000 +4.7% 1.31 US$13,098
2014-11-17 2014-11-14 B Purchase GOLDBERG MICHAEL M Non-Executive Director
28,359 +10.9%
1.12
US$31,890 		28,359 +10.9% 1.12 US$31,890
2014-11-17 2014-11-13 B Purchase GOLDBERG MICHAEL M Non-Executive Director
71,641 +37.8%
1.06
US$75,853 		71,641 +37.8% 1.06 US$75,853
2014-11-12 2014-11-10 B Purchase FORD BRENDAN A Non-Executive Director
10,000 +5.9%
1.03
US$10,300 		10,000 +5.9% 1.03 US$10,300
2014-09-04 2014-09-02 S Sale Nordlicht Mark Large shareholder
60,000 -0.4%
1.36
US$81,552 		60,000 -0.4% 1.36 US$81,552
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
100 +1.0%
1.43
US$143 		100 +1.0% 1.43 US$143
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
500 +5.3%
1.43
US$712 		500 +5.3% 1.43 US$712
2014-05-15 2014-05-12 B Purchase Regan William J.

SVP-Global Reg Affairs&Quality

Officer
4,400 +88.0%
1.43
US$6,283 		4,400 +88.0% 1.43 US$6,283
2014-05-13 2014-05-09 B Purchase PYKETT MARK JEROME

CEO

Executive Director
10,000 +3.5%
1.34
US$13,400 		10,000 +3.5% 1.34 US$13,400
2013-11-08 2013-11-08 B Purchase PYKETT MARK JEROME

CEO

Executive Director
10,900 +2.8%
1.35
US$14,715 		10,900 +2.8% 1.35 US$14,715
2013-11-08 2013-11-08 B Purchase Cope Frederick O

SVP

Officer
3,500 +4.0%
1.43
US$5,005 		3,500 +4.0% 1.43 US$5,005
2013-11-08 2013-11-08 B Purchase LARSON BRENT L

EVP, CFO, Treas & Secy

Officer
5,000 +1.8%
1.39
US$6,950 		5,000 +1.8% 1.39 US$6,950
2013-11-08 2013-11-08 B Purchase FORD BRENDAN A Non-Executive Director
20,000 +16.8%
1.45
US$29,000 		20,000 +16.8% 1.45 US$29,000
2013-11-08 2013-11-08 B Purchase Troup Gordon A Non-Executive Director
20,000 +15.8%
1.36
US$27,158 		20,000 +15.8% 1.36 US$27,158
2013-03-18 2013-03-15 B Purchase Tulip Thomas H.

EVP & Chief Business Officer

Officer
17,500 +63.6%
2.82
US$49,350 		17,500 +63.6% 2.82 US$49,350
2013-03-18 2013-03-15 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
1,850 +0.5%
2.70
US$4,995 		1,850 +0.5% 2.70 US$4,995
2013-03-18 2013-03-15 B Purchase Troup Gordon A Non-Executive Director
7,000 +5.9%
2.70
US$18,893 		7,000 +5.9% 2.70 US$18,893
2013-03-18 2013-03-15 B Purchase Regan William J.

SVP-Global Regulatory Strategy

Officer
5,000 +inf%
2.71
US$13,550 		5,000 +inf% 2.71 US$13,550
2013-03-18 2013-03-15 B Purchase FORD BRENDAN A Non-Executive Director
5,000 +4.4%
2.71
US$13,550 		5,000 +4.4% 2.71 US$13,550
2012-11-09 2012-10-10 B Purchase Platinum-Montaur Life Sciences, LLC Large shareholder
37,030 +0.5%
2.56
US$94,797 		37,030 +0.5% 2.56 US$94,797
2012-11-09 2012-09-21 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
4,911 -0.1%
3.24
US$15,912 		4,911 -0.1% 3.24 US$15,912
2012-11-09 2012-09-19 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
21,700 -0.3%
3.22
US$69,874 		21,700 -0.3% 3.22 US$69,874
2012-09-14 2012-09-14 B Purchase Tulip Thomas H.

EVP & Chief Business officer
15,000 +120.0%
2.70
US$40,500 		15,000 +120.0% 2.70 US$40,500
2012-09-13 2012-09-12 B Purchase Troup Gordon A Non-Executive Director
5,000 +6.9%
2.64
US$13,185 		5,000 +6.9% 2.64 US$13,185
2012-09-13 2012-09-12 B Purchase FORD BRENDAN A Non-Executive Director
5,000 +7.5%
2.64
US$13,200 		5,000 +7.5% 2.64 US$13,200
2012-09-14 2012-09-11 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
4,000 +1.3%
2.64
US$10,552 		4,000 +1.3% 2.64 US$10,552
2012-11-09 2012-09-10 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
269,919 -3.8%
3.69
US$996,001 		269,919 -3.8% 3.69 US$996,001
2012-11-09 2012-09-10 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
20,500 -0.3%
3.75
US$76,875 		20,500 -0.3% 3.75 US$76,875
2012-11-09 2012-09-07 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
118,731 -1.6%
3.61
US$428,619 		118,731 -1.6% 3.61 US$428,619
2012-11-09 2012-09-06 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
2,200 -0.0%
3.71
US$8,162 		2,200 -0.0% 3.71 US$8,162
2012-11-09 2012-09-05 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
64,900 -0.9%
3.78
US$245,322 		64,900 -0.9% 3.78 US$245,322
2012-11-09 2012-09-04 S Sale Platinum-Montaur Life Sciences, LLC Large shareholder
205,521 -2.8%
3.80
US$780,980 		205,521 -2.8% 3.80 US$780,980
2012-09-13 2012-08-15 B Purchase Troup Gordon A Non-Executive Director
5,000 +7.5%
3.58
US$17,895 		5,000 +7.5% 3.58 US$17,895
2011-12-20 2011-12-19 PlS Planned sale BUPP DAVID C Non-Executive Director
7,814 -0.3%
2.54
US$19,848 		7,814 -0.3% 2.54 US$19,848
2011-12-20 2011-12-16 PlS Planned sale BUPP DAVID C Non-Executive Director
42,186 -1.5%
2.45
US$103,356 		42,186 -1.5% 2.45 US$103,356
2011-11-22 2011-11-21 PlS Planned sale BUPP DAVID C Non-Executive Director
10,000 -0.4%
2.19
US$21,900 		10,000 -0.4% 2.19 US$21,900
2011-11-22 2011-11-18 PlS Planned sale BUPP DAVID C Non-Executive Director
6,100 -0.2%
2.25
US$13,725 		6,100 -0.2% 2.25 US$13,725
2011-11-02 2011-11-01 PlS Planned sale BROWN RODGER A

Vice President

Officer
28,715 -13.1%
2.76
US$79,253 		28,715 -13.1% 2.76 US$79,253
2011-11-02 2011-11-01 PlS Planned sale LARSON BRENT L

SVP, CFO, Treas & Secy

Officer
12,500 -4.5%
2.75
US$34,375 		12,500 -4.5% 2.75 US$34,375
2011-10-19 2011-10-17 PlS Planned sale BUPP DAVID C Non-Executive Director
50,000 -1.9%
2.89
US$144,500 		50,000 -1.9% 2.89 US$144,500
2011-10-18 2011-09-15 B Purchase DRAKE PETER F Non-Executive Director
10,000 +inf%
3.08
US$30,780 		10,000 +inf% 3.08 US$30,780
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
1,100 +inf%
2.56
US$2,816 		1,100 +inf% 2.56 US$2,816
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
100 +3.1%
2.56
US$256 		100 +3.1% 2.56 US$256
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
500 +18.5%
2.60
US$1,300 		500 +18.5% 2.60 US$1,300
2011-08-23 2011-08-22 B Purchase PYKETT MARK JEROME

Pres. & CEO

Executive Director
2,700 +inf%
2.61
US$7,047 		2,700 +inf% 2.61 US$7,047
2011-08-23 2011-08-22 B Purchase Troup Gordon A Non-Executive Director
10,000 +25.0%
2.61
US$26,100 		10,000 +25.0% 2.61 US$26,100
2011-08-23 2011-08-19 B Purchase FORD BRENDAN A Non-Executive Director
20,000 +66.7%
2.51
US$50,200 		20,000 +66.7% 2.51 US$50,200
2011-08-23 2011-08-19 B Purchase Rowinsky Eric K Non-Executive Director
15,000 +inf%
2.55
US$38,250 		15,000 +inf% 2.55 US$38,250
2011-06-07 2011-06-03 PlS Planned sale BUPP DAVID C Non-Executive Director
234,000 -8.2%
4.52
US$1,057,680 		234,000 -8.2% 4.52 US$1,057,680
2011-06-03 2011-06-02 PlS Planned sale BUPP DAVID C Non-Executive Director
233,000 -8.4%
4.74
US$1,104,420 		233,000 -8.4% 4.74 US$1,104,420
2011-06-01 2011-05-27 S Sale Blair Anthony K

VP-Manufacturing & Operations

Officer
50,000 -100.0%
5.22
US$261,000 		50,000 -100.0% 5.22 US$261,000
Explore more

More insider trading research around Navidea Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America